CN Bio logoCN Bio logoCN Bio logoCN Bio logo
  • Products
    • Explore our solutions


      PhysioMimix™ products enable you to recreate complex human biology and accurately predict human drug responses

      PhysioMimix OOC

      PhysioMimix OOC systems
      Learn more

      Consumables

      • Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
      Learn more

      Models

      • Single-organ models
      • Multi-organ models

      Support packages

      • PhysioMimix™ support packages
  • Applications
    • Discover the applications


      Investigate the application areas that our PhysioMimix™ products and services support

      Learn more

      Disease modeling

      • Non-Alcoholic Steatohepatitis
      • Hepatitis B
      • Oncology
      • COVID-19
      Learn more

      Safety toxicology

      • Drug-induced liver injury
      • Immune-mediated toxicities
      Learn more

      ADME

      • Drug absorption
      • Drug metabolism
      • Drug bioavailability
      Learn more
  • Services
    • Studies as a service


      Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

      Learn more
      NAFLD / NASH icons

      NAFLD / NASH

      Drug-induced liver injury icon

      Drug-induced liver injury

      icon adme |

      ADME

      Oncology icon

      Oncology

  • Resources
  • Company
    • About us


      Meet the team, explore our culture and discover what to expect when working with us

      CN Bio team photo
      About us

      Latest news

      • The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

      • The U.S. FDA Modernization Act 2.0. Now the animal testing mandate is removed, learn what can be embraced in its place.

      • CN Bio appoints Dr Paul Brooks as Chief Executive Officer

      View all news

      Upcoming Events

      • SLAS2023

      • SOT 2023

      • WORD 2023

      • SLAS Europe 2023

      • MPS World Summit 2023

      View all events

      Join the team!

      View all jobs
  • Contact
  • Products
    • PhysioMimix™ OOC Microphysiological Systems
    • Consumables
      • PhysioMimix™ multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers
  • Contact
  • Skip to main content
  • Skip to footer
Chat live with an expert

Transform discovery with predictive human organ models


Generate human-specific efficacy and safety data with pioneering PhysioMimix™ single- and multi-organ-on-a-chip solutions.

scroll down
PhysioMimix systems

Areas to explore


Organ-on-a-chip (OOC) studies are being hailed as the key to faster, more accurate drug discovery. Explore how to harness the power of PhysioMimix™ in your own lab or via our contract research services.

Products icon

Products

Learn more about PhysioMimix and why it’s helping drive OOC adoption

Explore PhysioMimix OOC

Applications icon

Applications

Explore the varying application areas that PhysioMimix OOC helps support

PhysioMimix application areas

Services icon

Services

Access the power of PhysioMimix through our contract research service

Our OOC services

PhysioMimix™
Organ-on-a-chip


Model human biology in the lab with our microphysiological systems to improve the accuracy and efficiency of drug discovery.

  • Delivers human-relevant, translatable data
  • Single- and multi-organ capabilities
  • Flexible and customisable
  • Easy to adopt, simple to use
Explore PhysioMimix
PhysioMimix™ Organ-on-a-chip multi-organ system

What’s new?

Conference

My project 1 9 |

Meet us at SLAS

Our full US team will be out in attendance for the 2023 SLAS International Conference & Exhibition.

Peer Reviewed Article

ADME-pharmtech-article-2022

New ADME Article in PharmaTech

ADME Studies: Determining Promising Drug Compounds.

Video

physiomimix video |

Take a tour with our animated video

Explore how PhysioMimix is transforming the way human-relevant preclinical data is generated.

Company News

CNB728 fda feat pr v1 |

FDA expands collaboration with CN Bio

New research project to investigate the use of multi-organ MPS to improve estimation of human drug bioavailability.

Speak to our experts

Speak directly with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

+44 (0) 1223 737941

Privacy | Cookies | Terms | Regulatory | Accessibility

©2023 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. 978184563

Latest news

  • The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system January 17, 2023
  • The U.S. FDA Modernization Act 2.0. Now the animal testing mandate is removed, learn what can be embraced in its place. January 9, 2023
  • CN Bio appoints Dr Paul Brooks as Chief Executive Officer December 19, 2022

Upcoming events

MPS World Summit 2023 June 26-30, 2023

SLAS Europe 2023 May 22-26, 2023

SLAS2023 February 25 - March 1, 2023